Thomas A Fitzgerald Transcode Therapeutics, Inc. (RNAZ) insider trading activity
Thomas A Fitzgerald is Interim CEO, CFO of Transcode Therapeutics, Inc.. Currently has a direct ownership of 56,318 shares of RNAZ, which is worth approximately $27,032. The most recent transaction as insider was on Sep 28, 2023, when has been sold 49,350 shares (Common Stock) at a price of $0.51 per share, resulting in proceeds of $25,168. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
56.3K
0%
3M change
0%
12M change
Total Value Held
$27,032
Thomas A Fitzgerald Transaction History
TAF
Thomas A Fitzgerald
Interim CEO, CFO
Boston, MA